Cargando…

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication

OBJECTIVE: In large cohort studies comorbidities are usually self-reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship between self-reported comorbidities and medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucke, Tanja, Herrera, Ronald, Wacker, Margarethe, Holle, Rolf, Biertz, Frank, Nowak, Dennis, Huber, Rudolf M., Söhler, Sandra, Vogelmeier, Claus, Ficker, Joachim H., Mückter, Harald, Jörres, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085029/
https://www.ncbi.nlm.nih.gov/pubmed/27792735
http://dx.doi.org/10.1371/journal.pone.0163408
_version_ 1782463488635961344
author Lucke, Tanja
Herrera, Ronald
Wacker, Margarethe
Holle, Rolf
Biertz, Frank
Nowak, Dennis
Huber, Rudolf M.
Söhler, Sandra
Vogelmeier, Claus
Ficker, Joachim H.
Mückter, Harald
Jörres, Rudolf A.
author_facet Lucke, Tanja
Herrera, Ronald
Wacker, Margarethe
Holle, Rolf
Biertz, Frank
Nowak, Dennis
Huber, Rudolf M.
Söhler, Sandra
Vogelmeier, Claus
Ficker, Joachim H.
Mückter, Harald
Jörres, Rudolf A.
author_sort Lucke, Tanja
collection PubMed
description OBJECTIVE: In large cohort studies comorbidities are usually self-reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship between self-reported comorbidities and medical records or pharmacy data, but none of them provided a structured, documented method of evaluation. We thus developed a detailed procedure to compare self-reported comorbidities with information on comorbidities derived from medication inspection. This was applied to the data of the German COPD cohort COSYCONET. METHODS: Approach I was based solely on ICD10-Codes for the diseases and the indications of medications. To overcome the limitations due to potential non-specificity of medications, Approach II was developed using more detailed information, such as ATC-Codes specific for one disease. The relationship between reported comorbidities and medication was expressed by a four-level concordance score. RESULTS: Approaches I and II demonstrated that the patterns of concordance scores markedly differed between comorbidities in the COSYCONET data. On average, Approach I resulted in more than 50% concordance of all reported diseases to at least one medication. The more specific Approach II showed larger differences in the matching with medications, due to large differences in the disease-specificity of drugs. The highest concordance was achieved for diabetes and three combined cardiovascular disorders, while it was substantial for dyslipidemia and hyperuricemia, and low for asthma. CONCLUSION: Both approaches represent feasible strategies to confirm self-reported diagnoses via medication. Approach I covers a broad spectrum of diseases and medications but is limited regarding disease-specificity. Approach II uses the information from medications specific for a single disease and therefore can reach higher concordance scores. The strategies described in a detailed and reproducible manner are generally applicable in large studies and might be useful to extract as much information as possible from the available data.
format Online
Article
Text
id pubmed-5085029
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50850292016-11-04 Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication Lucke, Tanja Herrera, Ronald Wacker, Margarethe Holle, Rolf Biertz, Frank Nowak, Dennis Huber, Rudolf M. Söhler, Sandra Vogelmeier, Claus Ficker, Joachim H. Mückter, Harald Jörres, Rudolf A. PLoS One Research Article OBJECTIVE: In large cohort studies comorbidities are usually self-reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship between self-reported comorbidities and medical records or pharmacy data, but none of them provided a structured, documented method of evaluation. We thus developed a detailed procedure to compare self-reported comorbidities with information on comorbidities derived from medication inspection. This was applied to the data of the German COPD cohort COSYCONET. METHODS: Approach I was based solely on ICD10-Codes for the diseases and the indications of medications. To overcome the limitations due to potential non-specificity of medications, Approach II was developed using more detailed information, such as ATC-Codes specific for one disease. The relationship between reported comorbidities and medication was expressed by a four-level concordance score. RESULTS: Approaches I and II demonstrated that the patterns of concordance scores markedly differed between comorbidities in the COSYCONET data. On average, Approach I resulted in more than 50% concordance of all reported diseases to at least one medication. The more specific Approach II showed larger differences in the matching with medications, due to large differences in the disease-specificity of drugs. The highest concordance was achieved for diabetes and three combined cardiovascular disorders, while it was substantial for dyslipidemia and hyperuricemia, and low for asthma. CONCLUSION: Both approaches represent feasible strategies to confirm self-reported diagnoses via medication. Approach I covers a broad spectrum of diseases and medications but is limited regarding disease-specificity. Approach II uses the information from medications specific for a single disease and therefore can reach higher concordance scores. The strategies described in a detailed and reproducible manner are generally applicable in large studies and might be useful to extract as much information as possible from the available data. Public Library of Science 2016-10-28 /pmc/articles/PMC5085029/ /pubmed/27792735 http://dx.doi.org/10.1371/journal.pone.0163408 Text en © 2016 Lucke et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lucke, Tanja
Herrera, Ronald
Wacker, Margarethe
Holle, Rolf
Biertz, Frank
Nowak, Dennis
Huber, Rudolf M.
Söhler, Sandra
Vogelmeier, Claus
Ficker, Joachim H.
Mückter, Harald
Jörres, Rudolf A.
Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title_full Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title_fullStr Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title_full_unstemmed Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title_short Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
title_sort systematic analysis of self-reported comorbidities in large cohort studies – a novel stepwise approach by evaluation of medication
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085029/
https://www.ncbi.nlm.nih.gov/pubmed/27792735
http://dx.doi.org/10.1371/journal.pone.0163408
work_keys_str_mv AT lucketanja systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT herreraronald systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT wackermargarethe systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT hollerolf systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT biertzfrank systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT nowakdennis systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT huberrudolfm systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT sohlersandra systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT vogelmeierclaus systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT fickerjoachimh systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT muckterharald systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT jorresrudolfa systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication
AT systematicanalysisofselfreportedcomorbiditiesinlargecohortstudiesanovelstepwiseapproachbyevaluationofmedication